vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and Life360, Inc. (LIF). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $146.0M, roughly 1.4× Life360, Inc.). Life360, Inc. runs the higher net margin — 88.8% vs 8.3%, a 80.6% gap on every dollar of revenue. On growth, Life360, Inc. posted the faster year-over-year revenue change (26.4% vs 12.9%). COLLEGIUM PHARMACEUTICAL, INC produced more free cash flow last quarter ($122.4M vs $36.6M). Over the past eight quarters, Life360, Inc.'s revenue compounded faster (36.6% CAGR vs 19.1%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
Life360, Inc. develops family-focused safety and connectivity platforms. Core offerings include real-time location sharing, emergency alerts, driving behavior analysis tools and identity theft protection. It serves consumer markets across North America, Europe and Asia-Pacific, with most revenue from tiered premium subscription plans.
COLL vs LIF — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $205.4M | $146.0M |
| Net Profit | $17.0M | $129.7M |
| Gross Margin | 62.5% | 75.1% |
| Operating Margin | 29.6% | 6.1% |
| Net Margin | 8.3% | 88.8% |
| Revenue YoY | 12.9% | 26.4% |
| Net Profit YoY | 35.3% | 1425.9% |
| EPS (diluted) | $0.48 | $1.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $146.0M | ||
| Q3 25 | $209.4M | $124.5M | ||
| Q2 25 | $188.0M | $115.4M | ||
| Q1 25 | $177.8M | $103.6M | ||
| Q4 24 | $181.9M | $115.5M | ||
| Q3 24 | $159.3M | $92.9M | ||
| Q2 24 | $145.3M | $84.9M | ||
| Q1 24 | $144.9M | $78.2M |
| Q4 25 | $17.0M | $129.7M | ||
| Q3 25 | $31.5M | $9.8M | ||
| Q2 25 | $12.0M | $7.0M | ||
| Q1 25 | $2.4M | $4.4M | ||
| Q4 24 | $12.5M | $8.5M | ||
| Q3 24 | $9.3M | $7.7M | ||
| Q2 24 | $19.6M | $-11.0M | ||
| Q1 24 | $27.7M | $-9.8M |
| Q4 25 | 62.5% | 75.1% | ||
| Q3 25 | 61.7% | 78.0% | ||
| Q2 25 | 57.7% | 78.4% | ||
| Q1 25 | 54.8% | 80.6% | ||
| Q4 24 | 54.0% | 74.0% | ||
| Q3 24 | 60.8% | 75.4% | ||
| Q2 24 | 62.5% | 75.0% | ||
| Q1 24 | 63.1% | 76.7% |
| Q4 25 | 29.6% | 6.1% | ||
| Q3 25 | 29.7% | 4.6% | ||
| Q2 25 | 18.7% | 1.7% | ||
| Q1 25 | 12.2% | 2.1% | ||
| Q4 24 | 20.9% | 4.9% | ||
| Q3 24 | 21.9% | -5.3% | ||
| Q2 24 | 32.7% | -2.8% | ||
| Q1 24 | 34.1% | -8.2% |
| Q4 25 | 8.3% | 88.8% | ||
| Q3 25 | 15.0% | 7.9% | ||
| Q2 25 | 6.4% | 6.1% | ||
| Q1 25 | 1.4% | 4.2% | ||
| Q4 24 | 6.9% | 7.4% | ||
| Q3 24 | 5.9% | 8.3% | ||
| Q2 24 | 13.5% | -12.9% | ||
| Q1 24 | 19.1% | -12.5% |
| Q4 25 | $0.48 | $1.53 | ||
| Q3 25 | $0.84 | $0.11 | ||
| Q2 25 | $0.34 | $0.08 | ||
| Q1 25 | $0.07 | $0.05 | ||
| Q4 24 | $0.36 | $0.14 | ||
| Q3 24 | $0.27 | $0.09 | ||
| Q2 24 | $0.52 | $-0.15 | ||
| Q1 24 | $0.71 | $-0.14 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $494.3M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $548.2M |
| Total Assets | $1.7B | $959.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $494.3M | ||
| Q3 25 | $285.9M | $455.7M | ||
| Q2 25 | $222.2M | $432.7M | ||
| Q1 25 | $197.8M | $168.9M | ||
| Q4 24 | $162.8M | $159.2M | ||
| Q3 24 | $120.0M | $159.0M | ||
| Q2 24 | $271.6M | $160.8M | ||
| Q1 24 | $318.0M | $73.4M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $5.2M |
| Q4 25 | $301.7M | $548.2M | ||
| Q3 25 | $274.8M | $391.4M | ||
| Q2 25 | $232.2M | $366.7M | ||
| Q1 25 | $234.4M | $376.3M | ||
| Q4 24 | $228.8M | $358.5M | ||
| Q3 24 | $234.3M | $339.7M | ||
| Q2 24 | $216.6M | $326.7M | ||
| Q1 24 | $222.2M | $239.8M |
| Q4 25 | $1.7B | $959.7M | ||
| Q3 25 | $1.6B | $787.5M | ||
| Q2 25 | $1.6B | $753.6M | ||
| Q1 25 | $1.6B | $455.4M | ||
| Q4 24 | $1.7B | $441.6M | ||
| Q3 24 | $1.6B | $427.4M | ||
| Q2 24 | $1.1B | $405.9M | ||
| Q1 24 | $1.1B | $318.8M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 0.02× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $36.8M |
| Free Cash FlowOCF − Capex | $122.4M | $36.6M |
| FCF MarginFCF / Revenue | 59.6% | 25.1% |
| Capex IntensityCapex / Revenue | 0.3% | 0.2% |
| Cash ConversionOCF / Net Profit | 7.25× | 0.28× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $86.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $36.8M | ||
| Q3 25 | $78.4M | $26.4M | ||
| Q2 25 | $72.4M | $13.3M | ||
| Q1 25 | $55.4M | $12.1M | ||
| Q4 24 | $84.6M | $12.3M | ||
| Q3 24 | $-9.0M | $6.3M | ||
| Q2 24 | $67.4M | $3.3M | ||
| Q1 24 | $61.9M | $10.7M |
| Q4 25 | $122.4M | $36.6M | ||
| Q3 25 | $78.3M | $25.6M | ||
| Q2 25 | $72.4M | $12.7M | ||
| Q1 25 | $54.6M | $11.9M | ||
| Q4 24 | $84.1M | $11.2M | ||
| Q3 24 | $-9.2M | $6.3M | ||
| Q2 24 | $67.1M | $3.2M | ||
| Q1 24 | $61.4M | — |
| Q4 25 | 59.6% | 25.1% | ||
| Q3 25 | 37.4% | 20.6% | ||
| Q2 25 | 38.5% | 11.0% | ||
| Q1 25 | 30.7% | 11.5% | ||
| Q4 24 | 46.2% | 9.7% | ||
| Q3 24 | -5.8% | 6.8% | ||
| Q2 24 | 46.2% | 3.8% | ||
| Q1 24 | 42.3% | — |
| Q4 25 | 0.3% | 0.2% | ||
| Q3 25 | 0.1% | 0.6% | ||
| Q2 25 | 0.0% | 0.6% | ||
| Q1 25 | 0.4% | 0.1% | ||
| Q4 24 | 0.3% | 1.0% | ||
| Q3 24 | 0.2% | 0.0% | ||
| Q2 24 | 0.2% | 0.1% | ||
| Q1 24 | 0.4% | 0.0% |
| Q4 25 | 7.25× | 0.28× | ||
| Q3 25 | 2.49× | 2.70× | ||
| Q2 25 | 6.05× | 1.90× | ||
| Q1 25 | 22.92× | 2.75× | ||
| Q4 24 | 6.75× | 1.45× | ||
| Q3 24 | -0.96× | 0.83× | ||
| Q2 24 | 3.44× | — | ||
| Q1 24 | 2.23× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
